Connect Biopharma to Present at Two Upcoming Investor Conferences in June
Provided By GlobeNewswire
Last update: May 28, 2025
SAN DIEGO, May 28, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma” or the “Company”), a clinical-stage biopharmaceutical company focused on transforming acute and chronic care of asthma and chronic obstructive pulmonary disease (COPD), today announced that company management will participate in the following upcoming conferences:
Read more at globenewswire.com
